The complexity of evolving prescription drug requirements has created challenges for manufacturer compliance efforts. Colorado enacted a drug pricing transparency law that requires pharmaceutical manufacturers to disclose in writing the names and wholesale average cost (WAC) of three generic prescription drugs from the same therapeutic class. Conexus recognized an opportunity to improve compliance and greatly reduce risk by automating the process for our client.
A clinical-stage oncology biotechnology company did not have adequate resources required to execute a strategic communication plan announcing their regulatory approval. Our flexible services created a unique opportunity for the client to leverage marketing automation tools and templates to bolster the impact and effectiveness of their communications.